Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Amicus Therapeutics (FOLD) over the last 16 years, with Dec 2024 value amounting to $3.5 million.

  • Amicus Therapeutics' Other Operating Expenses fell 13.64% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 7.11%. This contributed to the annual value of $3.5 million for FY2024, which is 237.32% up from last year.
  • According to the latest figures from FY2024, Amicus Therapeutics' Other Operating Expenses is $3.5 million, which was up 237.32% from -$2.6 million recorded in FY2023.
  • In the past 5 years, Amicus Therapeutics' Other Operating Expenses registered a high of $3.5 million during FY2024, and its lowest value of -$6.5 million during FY2021.
  • Its 3-year average for Other Operating Expenses is -$38,000, with a median of -$1.1 million in 2022.
  • Per our database at Business Quant, Amicus Therapeutics' Other Operating Expenses plummeted by 139.61% in 2023 and then soared by 237.32% in 2024.
  • Over the past 5 years, Amicus Therapeutics' Other Operating Expenses (Yearly) stood at -$3.1 million in 2020, then slumped by 107.19% to -$6.5 million in 2021, then skyrocketed by 83.45% to -$1.1 million in 2022, then plummeted by 139.61% to -$2.6 million in 2023, then surged by 237.32% to $3.5 million in 2024.